Project Type:
IndependentPrincipal Investigator Name:
Flora Hammond, M.D.Principal Investigator Email:
flora.hammond@rhin.comStart Date:
10/01/2012End Date:
09/30/2017Participating Centers:
Target Population(s):
Project Website:
Abstract:
A prospective randomized placebo controlled trial off the efficacy of buspirone in treating post-TBI irritability or aggression. Buspirone, sold under the brand names Buspar and Vanspar, is primarily prescribed to treat anxiety disorders or short-term symptoms of anxiety and has not been specifically evaluated for treating irritability or aggression after TBI.